Mutations in presenilin-1 (PS-1), presenilin-2 (PS-2), or amyloid precursor protein (APP) lead to early adult onset AD, characterized by Aβ plaques, neuroinflammation, and increased oxidative stress. Here, PSEN2 is linked to Alzheimer disease.